But knockdown studies conflate blocking the WIN site of WDR5 with loss of the entire protein, and because WDR5 is pan-essential23 cannot explain how WIN site inhibitors show cancer cell-selective inhibition in vitro6,11,17. This evidence concerns the gene FOXM1 and cancer.